AI assistant
Sending…
RESMED INC — Director's Dealing 2020
Nov 21, 2020
30071_dirs_2020-11-20_72935364-6c39-4ed7-9695-2e12dee5dac5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2020-11-20
Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-11-19 | ResMed Common Stock Options | $211.76 | A | 7702 | Acquired | 2027-11-19 | ResMed Common Stock (7702) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 144005 | Direct |
Footnotes
F1: Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2021, 2022 and 2023.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Regulatory Filings
2026
Jan 29